Efficacy of Intravenous Butorphanol for Preventing Epidural-Related Maternal Fever (ERMF) During Epidural Labor Analgesia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
A low dose of butorphanol intravenously used at the onset of EA in women undergoing vaginal delivery could effectively reduce the incidence of ERMF. Butorphanol may serve as a potential intervention for preventing ERMF in future.
Authors
- Caijuan Li (ORCID: https://orcid.org/0000-0003-1811-9758)
- Xu‐Lin Chen (ORCID: https://orcid.org/0000-0002-7822-1618)
- Shiqin Xu (ORCID: https://orcid.org/0000-0002-3833-575X)
- Yao Zhang (ORCID: https://orcid.org/0000-0002-6509-0946)
- Shanwu Feng (ORCID: https://orcid.org/0000-0002-5946-2811)
Institutions
- Nanjing Maternity and Child Health Care Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Drug Design Development and Therapy
- Published
- 2025-10-31
- DOI
- https://doi.org/10.2147/dddt.s547255
- Citations
- 1
- Primary Topic
- Preterm Birth and Chorioamnionitis
- Type
- article
- Field-Weighted Citation Impact
- 1.35
Funders
- Strong